Previous close | 157.00 |
Open | 159.00 |
Bid | 155.00 x 100000 |
Ask | 156.00 x 100000 |
Day's range | 156.00 - 159.00 |
52-week range | 114.00 - 168.00 |
Volume | |
Avg. volume | 2 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 23 July 2024 - 29 July 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Universal Health Services (UHS) could produce exceptional returns because of its solid growth attributes.
Continued solid uptake of BD's (BDX) products is expected to have driven fiscal second-quarter revenues.
Encompass Health (EHC) increases its guidance for net operating revenues, which is in the range of $5.25-$5.325 million for 2024.